COVID-19 Vaccines

FEMA will be providing American Sign Language interpreters, Certified Deaf Interpreters , and a Spanish-speaking deaf interpreter on site.

Thirty-nine percent of the nation's adult population has been fully vaccinated, according to the Centers for Disease Control and Prevention.

As a powerful second COVID surge ravages their home country, those in the Philadelphia region with family in India cannot simply stand by and watch.

Pa.’s former Health Secretary Dr. Rachel Levine, who now serves in that role at the federal level, visited the FEMA vaccination clinic in Center City.

The N.J. Health Department announced that any residents eligible for the COVID-19 vaccine can get their shots at its six megasites without an appointment.

Researchers are working on tests that can be performed using a blood sample that will determine not only whether a COVID-19 vaccine will work but also for how long.

With the Johnson & Johnson vaccine back online, Montgomery County is changing some COVID-19 vaccination sites.

This summer, New Jersey’s sleepaway camps will be allowed to reopen. State health officials said there were no COVID outbreaks at day camps last summer.

After an 11-day pause, health departments across South Jersey said they will resume use of the Johnson & Johnson vaccine to reach the state’s most vulnerable residents.

Philly has notified vaccine providers they can resume use of the Johnson & Johnson vaccine. Pa. is also increasing efforts to vaccinate residents who are unable to leave home.

It’s been more than a year of physical distancing and change. WHYY’s Health Desk Help Desk asked when, and how, life will resume post-pandemic?

You’re more likely to win the lottery than develop this severe COVID vaccine reaction. But for a Manayunk woman, the lowest of odds changed her life.

This stark access gap is prompting increased calls across the world for the U.S. to start shipping vaccine supplies to poorer countries.

Pregnant individuals reported pain at the injection site more frequently than their nonpregnant counterparts but fewer follow-up symptoms such as headache, chills, muscle pain

A U.S. health panel says it’s time to resume use of Johnson & Johnson’s COVID-19 vaccine, despite a very rare risk of blood clots.